You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anemia, Refractory, with Excess of Blasts

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid

Completed
  • Adult Acute Myeloid Leukemia in Remission
  • +16 more
  • iodine I 131 monoclonal antibody BC8
  • +7 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Nov 8, 2019

Myelodysplastic Syndrome, MDS, Refractory Anemia With Excess Blasts Trial in Worldwide (rigosertib, Any approved or

Terminated
  • Myelodysplastic Syndrome
  • +3 more
  • La Jolla, California
  • +157 more
Sep 22, 2022

Cancer, MDS-EB, MDS Trial in Athens, Southampton, Sheffield (INKmune)

Recruiting
  • Cancer
  • +4 more
  • INKmune
  • Athens, Attiki, Greece
  • +2 more
Jul 3, 2023

Acute Myeloid Leukemia, Blasts 30 Percent or Less of Bone Marrow Nucleated Cells, Chronic Myelomonocytic Leukemia Trial in

Completed
  • Acute Myeloid Leukemia
  • +5 more
  • DEC-205/NY-ESO-1 Fusion Protein CDX-1401
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 4, 2021

Chronic Myelomonocytic Leukemia, Chronic Myelomonocytic Leukemia-1, Chronic Myelomonocytic Leukemia-2 Trial in Canada, United

Active, not recruiting
Has Results
  • Chronic Myelomonocytic Leukemia
  • +6 more
  • Birmingham, Alabama
  • +297 more
Jan 28, 2023

Chronic Myelomonocytic Leukemia, de Novo MDS, MDS Trial in Cleveland (other, drug, genetic)

Completed
Has Results
  • Chronic Myelomonocytic Leukemia
  • +7 more
  • flow cytometry
  • +7 more
  • Cleveland, Ohio
  • +1 more
Feb 21, 2019

Acute Myeloid Leukemia, Myelodysplasia Trial in United States (MGTA-117)

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplasia
  • MGTA-117
  • Duarte, California
  • +7 more
Nov 23, 2022

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +19 more
  • umbilical cord blood transplantation
  • +7 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Feb 27, 2019

Leukemia, MDS Trial (drug, procedure, radiation)

Active, not recruiting
  • Leukemia
  • Myelodysplastic Syndromes
  • (no location specified)
Feb 17, 2022

Drug/Agent Toxicity by Tissue/Organ, Leukemia, MDS Trial in Chicago, Kankakee (amifostine trihydrate, cytarabine, mitoxantrone

Withdrawn
  • Drug/Agent Toxicity by Tissue/Organ
  • +3 more
  • amifostine trihydrate
  • +2 more
  • Chicago, Illinois
  • +3 more
Jan 31, 2023

MDS (MDS) Trial in United States (Alvocidib Plus Decitabine (during dose escalation only) or Azacitidine)

Completed
  • Myelodysplastic Syndromes (MDS)
  • Alvocidib Plus Decitabine (during dose escalation only) or Azacitidine
  • Chicago, Illinois
  • +11 more
Apr 4, 2022

Fanconi Anemia Trial in Minneapolis (anti-thymocyte globulin, filgrastim, busulfan)

Completed
Has Results
  • Fanconi Anemia
  • anti-thymocyte globulin
  • +6 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Nov 4, 2021

Acute Myeloid Leukemia, MDS Trial in Ulm (drug, combination product, other)

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Berlin, Germany
  • +9 more
Jan 13, 2023

Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Buffalo (biological, drug, radiation)

Completed
Has Results
  • Chronic Myeloproliferative Disorders
  • +7 more
  • anti-thymocyte globulin
  • +8 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 19, 2021

Steroid-refractory Diamond-Blackfan Anemia (DBA) Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Bitopertin)

Not yet recruiting
  • Steroid-refractory Diamond-Blackfan Anemia (DBA)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 28, 2023

MDS, Del(5Q), Anemia Trial in Italy (Luspatercept Injection [Reblozyl])

Recruiting
  • Myelodysplastic Syndromes
  • +3 more
  • Luspatercept Injection [Reblozyl]
  • Alessandria, Italy
  • +22 more
Jun 20, 2023

Bortezomib, Acute Myeloid Leukemia Trial in Wuhan (DAG pre-excitation regimen with Bortezomib)

Recruiting
  • Bortezomib
  • Acute Myeloid Leukemia
  • DAG pre-excitation regimen with Bortezomib
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Jul 31, 2023

MDS Trial in Worldwide (Oral Azacitidine, Durvalumab)

Active, not recruiting
Has Results
  • Myelodysplastic Syndromes
  • New Haven, Connecticut
  • +65 more
Aug 19, 2022

MDS, MDS, RAEB Trial in Worldwide (ON 01910.Na)

Completed
  • Myelodysplastic Syndromes
  • +3 more
  • ON 01910.Na
  • Scottsdale, Arizona
  • +86 more
Jun 29, 2020

Leukemia Trial in Marseille (blood sample, Stem cell donation)

Recruiting
  • Leukemia
  • blood sample
  • Stem cell donation
  • Marseille, France
    Assistance Publique Hôpitaux de Marseille
Mar 30, 2021

MDS Trial in Canada, United States (anti-thymocyte globulin)

Completed
  • Myelodysplastic Syndromes
  • anti-thymocyte globulin
  • Washington, District of Columbia
  • +27 more
Jan 24, 2021

MDS, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in United States (ASTX727 + Day 2 Food, ASTX727 + Day 4 Food)

Completed
  • Myelodysplastic Syndromes
  • +2 more
  • ASTX727 + Day 2 Food
  • ASTX727 + Day 4 Food
  • Buffalo, New York
  • +3 more
Feb 16, 2020

Chronic Myeloproliferative Disorders, Leukemia, Multiple Myeloma and Malignant Plasma Cell Tumors Trial in Tampa (busulfan,

Completed
  • Chronic Myeloproliferative Disorders
  • +4 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute at Universit
Dec 9, 2020

AML, MDS Trial in Tuebingen (Decitabine, Venetoclax)

Recruiting
  • AML
  • MDS
  • Tuebingen, Baden-Wuerttemberg, Germany
    University Hospital
Nov 30, 2023

Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Cleveland (biological, drug, procedure)

Completed
  • Chronic Myeloproliferative Disorders
  • +5 more
  • anti-thymocyte globulin
  • +5 more
  • Cleveland, Ohio
    Case Medical Center, University Hospitals Seidman Cancer Center,
Jul 23, 2020